Table 4.
Antimicrobial susceptibility patterns of Shigella isolates among diarrheic pediatric population attended at selected Gondar town Healthcare institutions, Northwest Ethiopia, 2018
| Antibiotic Disc | Shigella species (n = 29) | ||
|---|---|---|---|
| S (%) | I (%) | R (%) | |
| Amoxicillin (AMX) | 1(3.4%) | 1 (3.4%) | 27 (93.1%) |
| Norfloxacin (NOR) | 22 (75.9%) | 5 (17.2%) | 2 (6.9%) |
| Cotrimoxazole (SXT) | 5 (17.2%) | 12 (41.4%) | 12 (41.4%) |
| Amoxicillin-clavulanate (AMC) | 14 (48.3%) | 12 (41.4%) | 3 (10.3%) |
| Chloramphenicol (CAF) | 5 (17.2%) | 11 (37.9%) | 13 (44.8%) |
| Tetracycline (TE) | 2 (6.9%) | 1 (3.4%) | 26 (89.7%) |
| Nitrofurantoin (NIT) | 27(93.1%) | 2 (6.9%) | 0 (0.0%) |
| Azithromycin (AZM) | 13 (44.8%) | 6 (20.7%) | 10 (34.5%) |
S Susceptible, I Intermediate, R Resistance